News
Current position:Product Center > Cell lines > Cytokines > IL-2 > H_IL2 Reporter Cell Line
H_IL2 Reporter Cell Line
Description
Cat. No: GM-C16846
Product: H_IL2 Reporter Cell Line


Interleukin-2 (IL-2) is an important cytokine that mainly plays a regulatory role in the immune system. It works by binding to IL-2 receptors on the surface of lymphocytes, activating a series of signaling pathways that influence the proliferation and activity of immune cells.

The IL-2 receptor is made up of three chains: IL-2Rα, IL-2Rβ, and IL-2Rγ, which exist as a heterotrimer. When IL-2 binds to its receptor, it activates the JAK signaling pathway, which in turn activates the transcription factor STAT. The phosphorylated STATs form dimers or tetramers and move into the cell nucleus, regulating the expression of specific genes to promote the immune response.

H_IL2 Reporter Cell Line is a clonal stable cell line constructed using lentiviral technology, constitutive expression of the IL-2Rβ gene, and it endogenously expresses IL-2Rα and IL-2Rγ, along with signal-dependent expression of a luciferase reporter gene. When IL-2 binds to IL-2R, it activates downstream signaling pathways, leading to the expression of luciferase. The luciferase activity measurement indicates the activation level of the signaling pathway and can thus be used to evaluate the in vitro effects of drugs related to IL-2.
Data
Response to Recombinant Human IL-2. The H_IL2 Reporter Cell Line (Cat. GM-C16846) at a concentration of 1E5 cells/well (96-well format) was stimulated with serial dilutions of Recombinant Human IL-2 (Novoprotein/C013) in assay buffer (RPMI 1640 + 1% FBS + 1%P.S) for 16 hours. The firefly luciferase activity was measured using the GMOne-Step Luciferase Reporter Gene Assay Kit (Cat. GM-040503). The maximum induction fold was approximately [10.2]. Data are shown by drug mass concentration.
The passage stability of response to Recombinant Human IL-2. The passage 2 and 15 of H_IL2 Reporter Cell Line (Cat. GM-C16846) at a concentration of 1E5 cells/well (96-well format) was stimulated with serial dilutions of Recombinant Human IL-2 (Novoprotein/C013) in assay buffer (RPMI 1640 + 1% FBS + 1%P.S) for 16 hours. The firefly luciferase activity was measured using the GMOne-Step Luciferase Reporter Gene Assay Kit (Cat. GM-040503). Data are shown by drug mass concentration.
Specifications
Cat. NoGM-C16846
ProductH_IL2 Reporter Cell Line
Product Format1 vial of frozen cells
Quantity3E6 Cells per vial,1 mL
Storage ConditionsLiquid nitrogen immediately upon receipt
Recovery MediumRPMI 1640+10% FBS+1% P.S+ 2 ng/mL GM-CSF
Growth mediumRPMI 1640+10% FBS+1% P.S+2 ng/mL GM-CSF+3 μg/mL Blasticidin+0.25 μg/mL Puromycin
NoteNone
Freezing Medium90% FBS+10% DMSO
Growth propertiesSuspension
Growth Conditions37°C, 5% CO₂
Safety considerationsBiosafety Level 2
Mycoplasma TestingThe cell line has been screened to confirm the absence of Mycoplasma species.
Materials
ReagentOrdering Information
RPMI 1640gibco/C11875500BT
Fetal Bovine SerumCegrogen biotech/A0500-3010
Pen/StrepThermo/15140-122
Recombinant Human GM-CSFNovoprotein/C003
BlasticidinGenomeditech/GM-040404
PuromycinGenomeditech/GM-040401
Recombinant Human IL-2Novoprotein/C013
GMOne-Step Luciferase Reporter Gene Assay KitGenomeditech/GM-040503
Cell Culture

Cell Recovery

Recovery Medium: RPMI 1640+10% FBS+1% P.S+ 2 ng/mL GM-CSF

To insure the highest level of viability, thaw the vial and initiate the culture as soon as possible upon receipt. If upon arrival, continued storage of the frozen culture is necessary, it should be stored in liquid nitrogen vapor phase and not at -70°C. Storage at -70°C will result in loss of viability.

a)       Thaw the vial by gentle agitation in a 37°C water bath. To reduce the possibility of contamination, keep the O-ring and cap out of the water. Thawing should be rapid (approximately 2 - 3 minutes).

b)       Remove the vial from the water bath as soon as the contents are thawed, and decontaminate by dipping in or spraying with 70% ethanol. All of the operations from this point on should be carried out under strict aseptic conditions.

c)       Transfer the vial contents to a centrifuge tube containing 5.0 mL complete culture medium. And spin at approximately 176 x g for 5 minutes. Discard supernatant.

d)       Resuspend the cell pellet using the recommended complete medium and adjust the viable cell density to 4-6E5 cells/mL. Then dispense the suspension into an appropriate culture flask and initially place the flask in an upright position after thawing.

e)       Incubate the culture at 37°C in a suitable incubator. A 5% CO₂ in air atmosphere is recommended if using the medium described on this product sheet.

Cell Freezing

Freezing Medium: 90% FBS+10% DMSO

a)          Centrifuge at 176 x g for 3 minutes to collect cells.

b)         Resuspend the cells in pre-cooled freezing medium and adjust the cell density to 3E6 cells/mL.

c)          Aliquot 1 mL into each vial.

d)         Place the vial in a controlled-rate freezing container and store at -80°C for at least 1 day, then transfer to liquid nitrogen as soon as possible.

Cell passage

Growth medium: RPMI 1640+10% FBS+1% P.S+2 ng/mL GM-CSF+3 μg/mL Blasticidin+0.25 μg/mL Puromycin

Approximately 48 - 72 hours after the initial thawing, the cells can be passaged for the first time. After this initial passage, the culture medium can be adjusted to growth medium supplemented with antibiotics.

a)          This cell is a human erythroid leukemia cell, lymphoblast, growing in suspension.

b)         In the suspension, they appear as large, single, round cells. Cells shed a large accumulation of cytoplasmic granules in the culture, which should not be confused with bacteria!

c)          When the cell density reaches 1-1.2E6 cells/mL, perform a 1:2 to 1:3 split, ensuring subculturing every other day. It is essential to perform a full-volume centrifugation and medium replacement during passaging. Do not let the density exceed 1.2E6 cells/mL. It is recommended to use T-25 flasks for subculturing, and you can control the cell density for subculturing by counting.

Subcultivation Ratio: Maintain cultures at a cell concentraion between 4E5 and 6E5 viable cells/mL.

Medium Renewal: Every other day

Notes

a)          To minimize the presence of cytoplasmic granules, it is essential to passage the cells every other day when the cell density reaches 1-1.2E6 cells/mL. During passaging, perform a complete centrifugation and replace the culture medium to ensure appropriate cell density and cytokine concentration. Failure to do so may promote the growth of factor-independent subclones.

 

Current Position:Product Center > Cell lines > Cytokines > IL-2 > H_IL2 Reporter Cell Line
classify
H_IL2 Reporter Cell Line
Description
Cat. No: GM-C16846
Product: H_IL2 Reporter Cell Line


Interleukin-2 (IL-2) is an important cytokine that mainly plays a regulatory role in the immune system. It works by binding to IL-2 receptors on the surface of lymphocytes, activating a series of signaling pathways that influence the proliferation and activity of immune cells.

The IL-2 receptor is made up of three chains: IL-2Rα, IL-2Rβ, and IL-2Rγ, which exist as a heterotrimer. When IL-2 binds to its receptor, it activates the JAK signaling pathway, which in turn activates the transcription factor STAT. The phosphorylated STATs form dimers or tetramers and move into the cell nucleus, regulating the expression of specific genes to promote the immune response.

H_IL2 Reporter Cell Line is a clonal stable cell line constructed using lentiviral technology, constitutive expression of the IL-2Rβ gene, and it endogenously expresses IL-2Rα and IL-2Rγ, along with signal-dependent expression of a luciferase reporter gene. When IL-2 binds to IL-2R, it activates downstream signaling pathways, leading to the expression of luciferase. The luciferase activity measurement indicates the activation level of the signaling pathway and can thus be used to evaluate the in vitro effects of drugs related to IL-2.
Data
Response to Recombinant Human IL-2. The H_IL2 Reporter Cell Line (Cat. GM-C16846) at a concentration of 1E5 cells/well (96-well format) was stimulated with serial dilutions of Recombinant Human IL-2 (Novoprotein/C013) in assay buffer (RPMI 1640 + 1% FBS + 1%P.S) for 16 hours. The firefly luciferase activity was measured using the GMOne-Step Luciferase Reporter Gene Assay Kit (Cat. GM-040503). The maximum induction fold was approximately [10.2]. Data are shown by drug mass concentration.
The passage stability of response to Recombinant Human IL-2. The passage 2 and 15 of H_IL2 Reporter Cell Line (Cat. GM-C16846) at a concentration of 1E5 cells/well (96-well format) was stimulated with serial dilutions of Recombinant Human IL-2 (Novoprotein/C013) in assay buffer (RPMI 1640 + 1% FBS + 1%P.S) for 16 hours. The firefly luciferase activity was measured using the GMOne-Step Luciferase Reporter Gene Assay Kit (Cat. GM-040503). Data are shown by drug mass concentration.
Specifications
Cat. NoGM-C16846
ProductH_IL2 Reporter Cell Line
Product Format1 vial of frozen cells
Quantity3E6 Cells per vial,1 mL
Storage ConditionsLiquid nitrogen immediately upon receipt
Recovery MediumRPMI 1640+10% FBS+1% P.S+ 2 ng/mL GM-CSF
Growth mediumRPMI 1640+10% FBS+1% P.S+2 ng/mL GM-CSF+3 μg/mL Blasticidin+0.25 μg/mL Puromycin
NoteNone
Freezing Medium90% FBS+10% DMSO
Growth propertiesSuspension
Growth Conditions37°C, 5% CO₂
Safety considerationsBiosafety Level 2
Mycoplasma TestingThe cell line has been screened to confirm the absence of Mycoplasma species.
Materials
ReagentOrdering Information
RPMI 1640gibco/C11875500BT
Fetal Bovine SerumCegrogen biotech/A0500-3010
Pen/StrepThermo/15140-122
Recombinant Human GM-CSFNovoprotein/C003
BlasticidinGenomeditech/GM-040404
PuromycinGenomeditech/GM-040401
Recombinant Human IL-2Novoprotein/C013
GMOne-Step Luciferase Reporter Gene Assay KitGenomeditech/GM-040503
Cell Culture

Cell Recovery

Recovery Medium: RPMI 1640+10% FBS+1% P.S+ 2 ng/mL GM-CSF

To insure the highest level of viability, thaw the vial and initiate the culture as soon as possible upon receipt. If upon arrival, continued storage of the frozen culture is necessary, it should be stored in liquid nitrogen vapor phase and not at -70°C. Storage at -70°C will result in loss of viability.

a)       Thaw the vial by gentle agitation in a 37°C water bath. To reduce the possibility of contamination, keep the O-ring and cap out of the water. Thawing should be rapid (approximately 2 - 3 minutes).

b)       Remove the vial from the water bath as soon as the contents are thawed, and decontaminate by dipping in or spraying with 70% ethanol. All of the operations from this point on should be carried out under strict aseptic conditions.

c)       Transfer the vial contents to a centrifuge tube containing 5.0 mL complete culture medium. And spin at approximately 176 x g for 5 minutes. Discard supernatant.

d)       Resuspend the cell pellet using the recommended complete medium and adjust the viable cell density to 4-6E5 cells/mL. Then dispense the suspension into an appropriate culture flask and initially place the flask in an upright position after thawing.

e)       Incubate the culture at 37°C in a suitable incubator. A 5% CO₂ in air atmosphere is recommended if using the medium described on this product sheet.

Cell Freezing

Freezing Medium: 90% FBS+10% DMSO

a)          Centrifuge at 176 x g for 3 minutes to collect cells.

b)         Resuspend the cells in pre-cooled freezing medium and adjust the cell density to 3E6 cells/mL.

c)          Aliquot 1 mL into each vial.

d)         Place the vial in a controlled-rate freezing container and store at -80°C for at least 1 day, then transfer to liquid nitrogen as soon as possible.

Cell passage

Growth medium: RPMI 1640+10% FBS+1% P.S+2 ng/mL GM-CSF+3 μg/mL Blasticidin+0.25 μg/mL Puromycin

Approximately 48 - 72 hours after the initial thawing, the cells can be passaged for the first time. After this initial passage, the culture medium can be adjusted to growth medium supplemented with antibiotics.

a)          This cell is a human erythroid leukemia cell, lymphoblast, growing in suspension.

b)         In the suspension, they appear as large, single, round cells. Cells shed a large accumulation of cytoplasmic granules in the culture, which should not be confused with bacteria!

c)          When the cell density reaches 1-1.2E6 cells/mL, perform a 1:2 to 1:3 split, ensuring subculturing every other day. It is essential to perform a full-volume centrifugation and medium replacement during passaging. Do not let the density exceed 1.2E6 cells/mL. It is recommended to use T-25 flasks for subculturing, and you can control the cell density for subculturing by counting.

Subcultivation Ratio: Maintain cultures at a cell concentraion between 4E5 and 6E5 viable cells/mL.

Medium Renewal: Every other day

Notes

a)          To minimize the presence of cytoplasmic granules, it is essential to passage the cells every other day when the cell density reaches 1-1.2E6 cells/mL. During passaging, perform a complete centrifugation and replace the culture medium to ensure appropriate cell density and cytokine concentration. Failure to do so may promote the growth of factor-independent subclones.

 

Tel: 400-627-9288
Message consultation
reset
submit
Service
WhatApp
Phone
Message
Message consultation
reset
submit